National Cancer Institute

Total investments

103

Average round size

2M

Portfolio companies

83

Rounds per year

1.18

Lead investments

23

Follow on index

0.18

Exits

8

Areas of investment
BiotechnologyHealth CareHealth DiagnosticsEducationMedical DeviceMedicalLife SciencePharmaceuticalTherapeuticsUniversities

Summary

The leading representative office of defined Corporate Investor is situated in the Bethesda. The fund was located in North America if to be more exact in United States.

The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the National Cancer Institute, startups are often financed by U.S. Department of Defense, National Institutes of Health, National Heart, Lung and Blood Institute. The meaningful sponsors for the fund in investment in the same round are US Department of Energy, National Science Foundation, National Institutes of Health. In the next rounds fund is usually obtained by National Institute of Neurological Disorders and Stroke.

The usual things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this Corporate Investor is 62 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2019.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of more than 20 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Karmanos Cancer Institute, Wake Forest Baptist Medical Center, Rutgers Universityu2013New Brunswick Among the most popular fund investment industries, there are Health Diagnostics, Neuroscience.

Show more

Investments analytics

Analytics

Total investments
103
Lead investments
23
Exits
8
Rounds per year
1.18
Follow on index
0.18
Investments by industry
  • Biotechnology (55)
  • Health Care (48)
  • Therapeutics (31)
  • Medical (29)
  • Pharmaceutical (14)
  • Show 44 more
Investments by region
  • United States (97)
  • Canada (1)
  • Sweden (1)
Peak activity year
2022

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
31
Avg. valuation at time of investment
1M
Group Appearance index
0.06
Avg. company exit year
10
Avg. multiplicator
0.15
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.